Cargando…
Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
The outbreak of existing public health distress is threatening the entire world with emergence and rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel coronavirus disease 2019 (COVID-19) is mild in most people. However, in some elderly people with co-morbid condit...
Autores principales: | Bajad, Nilesh Gajanan, Rayala, Swetha, Gutti, Gopichand, Sharma, Anjali, Singh, Meenakshi, Kumar, Ashok, Singh, Sushil Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120892/ https://www.ncbi.nlm.nih.gov/pubmed/34870145 http://dx.doi.org/10.1016/j.crphar.2021.100026 |
Ejemplares similares
-
Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
por: Prasad, Kartikay, et al.
Publicado: (2021) -
Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents
por: Bajad, Nilesh Gajanan, et al.
Publicado: (2022) -
Recent progress in the development of potential drugs against SARS-CoV-2
por: Chen, Jianmin, et al.
Publicado: (2021) -
Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
por: Tao, Sijia, et al.
Publicado: (2021) -
Host directed therapies: COVID-19 and beyond
por: Tripathi, Devavrat, et al.
Publicado: (2021)